Microfluidic multi-input reactor for biocatalytic synthesis using transketolase. by Lawrence, J et al.
MJ
a
b
A
R
R
A
A
K
M
F
T
L
M
1
s
h
a
g
u
p
c
i
A
a
m
o
c
i
h
c
i
w
C
r
1
hJournal of Molecular Catalysis B: Enzymatic 95 (2013) 111– 117
Contents lists available at SciVerse ScienceDirect
Journal  of  Molecular  Catalysis B:  Enzymatic
jo ur nal home p age: www.elsev ier .com/ locate /molcatb
icroﬂuidic  multi-input  reactor  for  biocatalytic  synthesis  using  transketolase
ames  Lawrencea, Brian  O’Sullivana, Gary  J.  Lyea, Roland  Wohlgemuthb,  Nicolas  Szitaa,∗
Department of Biochemical Engineering, University College London, Torrington Place, London WC1E 7JE, UK
Sigma–Aldrich, Industriestrasse 25, 9470 Buchs, Switzerland
a  r  t  i  c  l e  i  n  f  o
rticle history:
eceived 31 January 2013
eceived in revised form 8 May  2013
ccepted 17 May  2013
vailable online 28 May 2013
a  b  s  t  r  a  c  t
Biocatalytic  synthesis  in  continuous-ﬂow  microreactors  is  of  increasing  interest  for  the  production  of
specialty  chemicals.  However,  the  yield  of  production  achievable  in  these  reactors  can  be  limited  by the
adverse  effects  of  high  substrate  concentration  on  the  biocatalyst,  including  inhibition  and  denaturation.
Fed-batch  reactors  have  been  developed  in order  to overcome  this  problem,  but  no continuous-ﬂow
solution  exists.  We  present  the  design  of a novel  multi-input  microﬂuidic  reactor,  capable  of  substrateeywords:
icro reactor
ed-batch
ransketolase
aser fabrication
icroﬂuidic reactor
feeding  at multiple  points,  as  a ﬁrst step  towards  overcoming  these  problems  in  a continuous-ﬂow  setting.
Using  the  transketolase-(TK)  catalysed  reaction  of  lithium  hydroxypyruvate  (HPA)  and  glycolaldehyde
(GA)  to  l-erythrulose  (ERY),  we  demonstrate  the  transposition  of  a fed-batch  substrate  feeding  strategy
to our  microﬂuidic  reactor.  We  obtained  a  4.5-fold  increase  in  output  concentration  and  a  5-fold  increase
in throughput  compared  with  a single  input  reactor.
© 2013 The Authors. Published by Elsevier B.V. All rights reserved.. Introduction
Microﬂuidic reactors are of increased interest for preparative
ynthetic work due to a variety of advantages such as improved
eat and mass transfer, mixing, safety, process intensiﬁcation, scal-
bility and reproducibility. As such they are being applied to a
rowing number of reactions in research and industry [1–4]. The
se of microreactors for catalytic asymmetric synthesis has a high
otential among the many different methodologies for the efﬁ-
ient and sustainable synthesis of valuable chiral compounds with
mproved control of reaction conditions and fast optimisation [5].
s biocatalytic asymmetric synthesis has proven to be a sustain-
ble and viable methodology in organic synthesis and industrial
anufacturing processes [6–9], efforts to combine the advantages
f biocatalysis and micro-reactor technology in a mutually beneﬁ-
ial way have started to create numerous new application areas of
nterest, including resolution of racemic mixtures, reactions using
azardous substrates or two-phase systems [10–21].
Transketolases have been shown to be useful biocatalysts for
reating new carbon–carbon bonds between aldehydes and the
rreversible two-carbon donor lithium hydroxypyruvate (HPA)
ith high selectivity, broad substrate speciﬁcity and a high degree
 This is an open-access article distributed under the terms of the Creative
ommons Attribution License, which permits unrestricted use, distribution and
eproduction in any medium, provided the original author and source are credited.
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381-1177/$ – see front matter ©  2013 The Authors. Published by Elsevier B.V. All rights 
ttp://dx.doi.org/10.1016/j.molcatb.2013.05.016of conversion. They therefore represent a highly attractive and
versatile biocatalytic platform technology with an ever-increasing
range of applications [22–27]. Since the scale-up to viable manufac-
turing processes requires also work on the process design, reaction
engineering and the optimisation of reaction conditions [28,29], the
application of microreactor technology to transketolase-catalyzed
carbon-carbon bond formation reactions is of fundamental interest
[30].
In a previous publication, we  have described the cascading of a
microﬂuidic reactor and a ﬁltration system for biocatalytic asym-
metric synthesis using transketolase [31]. The system was able to
fully convert HPA to the chiral product l-erythrulose (ERY) with
high enantiomeric purity, as well as separating out the transke-
tolase (TK) from the product, synthesising a pure pharmaceutical
intermediate in a continuous-ﬂow setting. However, the yield of
ERY was low relative to the typical output that would be expected
from chemical synthesis processes. Therefore it would be of great
value to investigate improvements of yield and throughput in such
devices.
The maximum product yield achievable with a T-channel reac-
tor design, such as that used in our previous publication, is heavily
dependent upon the effects of increased substrate concentration on
the biocatalyst. These effects include inhibition and denaturation
of the biocatalyst, with the latter causing clogging in continuous-
ﬂow reactors. In batch reactors, such effects are overcome by
controlled feeding of the substrate solution at deﬁned time points
(fed-batch mode). Miniaturised fed-batch reactors with opera-
tion volumes of 12 mL  [32] and 0.5 mL [33] exist, and could be
employed to maintain the concentration of the substrate below
reserved.
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lcheme 1. Reaction scheme. The transketolase-catalysed reaction of lithium
ydroxypyruvate (HPA) and glycolaldehyde (GA) to l-erythrulose (ERY).
nhibitory levels, allowing a higher product output. However these
eactors cannot be operated in continuous-ﬂow fashion, which
imits their applicability for multi-step process integration. Addi-
ionally, the signiﬁcant space-time-yield increases, characteristic
f continuous-ﬂow microreactors, cannot be exploited [34].
Reactor systems allowing injection of substrates at multiple
oints have been demonstrated for the purpose of controlling
xothermic chemical reactions. These systems were designed for
he continuous synthesis of allylcarbinol and of organometallic
ompounds, using multi-point feeding to control the formation
f impurities and the generation of heat respectively [35–37].
owever, such systems have not been applied to the problem of
ubstrate inhibition in biocatalytic reactions.
Continuous-ﬂow ‘loop-type’ microreactors designed to allow
he recycling of unconverted substrates have previously been
emonstrated [38,39]. It is possible to use these reactors to gradu-
lly feed substrate, however the continuous injection of substrate
nto the recycling loop at a single point means that a pure prod-
ct stream is fundamentally difﬁcult to achieve. The continuous
emoval of product also requires that the biocatalyst is either
mmobilised or removed by an in-line separation system, neces-
itating a more complex reactor design.
In this contribution, we combine a continuous-ﬂow reactor and
he principles of a fed-batch substrate feeding strategy for the ﬁrst
ime at the microﬂuidic scale. We  present the design of a novel
icroﬂuidic reactor capable of substrate feeding at multiple points.
e demonstrate the application of the reactor to the TK-catalysed
eaction of lithium hydroxypyruvate (HPA) and glycolaldehyde
GA) to l-erythrulose (ERY; Scheme 1).
. Experimental
.1. Reagents and analysis
Unless otherwise stated, all chemicals and reagents
Sigma–Aldrich, Gillingham, UK) were used without further
uriﬁcation.
Transketolase concentrations were measured by SDS-PAGE
lectrophoresis with 12% Tris–glycine resolving gel, using bovine
erum albumin standards. 20 g of total protein was  applied to each
ane and the samples were stained with Coomassie Blue R-250.
HPLC quantiﬁcation of lithium hydroxypyruvate (HPA) and l-
rythrulose (ERY) was performed on Aminex (Biorad, Hemel Hemp-
tead, UK) ion-exchange column (HPX-87H, 300 mm × 7.8 mm),
obile phase: 0.1% (v/v) aqueous triﬂuoroacetic acid (TFA) at
.6 mL  min−1. HPA and ERY were detected by UV absorption at
10 nm.
.2. Fabrication of the microﬂuidic multi-input reactor
The channels and cut-outs of the multi-input reactor (MIR) were
abricated in three layers of 1.5 mm poly(methylmethacrylate)
PMMA) using a CO2 laser marking head (Laserlines, Banbury, UK)
ith a maximum power of 25 W.  The features were ablated with a
ower of 50% and a mark speed (laser tracking speed) of 200 mm s−1
nd 10 mm s−1 for channels and cut-outs, respectively. The three
ayers were cleaned and thermally bonded (1.5 h, 105 ◦C, 90 min).lysis B: Enzymatic 95 (2013) 111– 117
The interconnect blocks of the MIR  were fabricated in 5 mm
polycarbonate (PC) with a micromilling machine (Folken IND, Glen-
dale, USA), using a 2 mm  end mill (Kyocera, Kyoto, Japan) with a
spindle speed of 10,000 rpm and feed rate of 80 mm  min−1. M3
and M6  taps were used to prepare the interconnect blocks for use.
Standard connection ﬁttings were used to attach tubing (P-221,
Upchurch Scientiﬁc, Oak Harbour, WA,  USA).
Plugs used to seal unused auxiliary inputs were fabricated in
poly(dimethylsiloxane) (PDMS; Sylgard 184, Dow Corning, Mid-
land, USA). A mould was milled from 5 mm PMMA  with a 2 mm
tool, a spindle speed of 7000 rpm and feed rate of 40 mm min−1.
The liquid polymer was prepared in a ratio of 10:1 (monomer to
curing agent), cast, degassed and then cured at 90 ◦C for 2 h.
2.3. Preparation of transketolase lysate
Transketolase lysates were prepared according to the method
of Matosevic et al. [40]. Overnight cultures of E. coli BL21gold (DE3)
(with transketolase-producing plasmid pQR791) were grown in 2 L
shake-ﬂasks from inoculation of 400 mL  Lysogeny Broth (LB) with
1 mL  of concentrated cell suspension in LB-glycerol stock solu-
tion (25%, v/v, glycerol, stored at −80 ◦C until inoculation). This
was incubated for 20–24 h at 37 ◦C, until the bacterial growth had
reached stationary phase as conﬁrmed by optical density measure-
ments. The contents of the ﬂask were transferred to 50 mL  falcon
tubes and centrifuged at 5000 rpm for 10 min. The supernatant was
discarded and the cell paste was  frozen at −80 ◦C until needed for
lysis and puriﬁcation.
For lysis, the cell paste was resuspended in 2 mL  50 mM Tris–HCl
buffer, cooled on ice and sonicated (10 cycles of 10 s on, 10 s off)
with a sonication probe (Soniprep 150, Sanyo, Japan). The sus-
pension was  then centrifuged at 5000 rpm for 10 min  and the
supernatant containing the enzyme was  stored at −20 ◦C until
required.
2.4. Continuous-ﬂow microﬂuidic reaction of HPA to ERY (with
multiple GA inputs)
Two separate solutions were used to perform the reac-
tion. The main reaction mixture (solution A) consisted of
0.069 mg  mL−1 clariﬁed transketolase lysate, different HPA concen-
trations (211/316/421/526 mM HPA, depending on experiment),
2.53 mM thiamine diphosphate (ThDP) and 10.3 mM MgCl2 in
50 mM Tris–HCl buffer, pH 7. The concentrations of the solutes
were chosen such that they would be diluted to the following con-
centrations once combined with the ﬁrst GA input: 0.066 mg mL−1
clariﬁed transketolase lysate, 200/300/400/500 mM HPA, 2.4 mM
thiamine diphosphate (TDP) and 9.8 mM MgCl2. The supplemen-
tary GA solution (solution B) consisted of 1 M GA in 50 mM Tris–HCl
buffer, pH 7 (Scheme 2).
The MIR  was primed with Tris–HCl buffer (50 mM,  pH 7). Solu-
tion A was pumped into the ﬁrst primary input of the reactor with
a single-drive syringe pump. Solution B was  pumped into the sec-
ond primary input, along with a number of auxiliary inputs, using a
dual-drive syringe pump adapted to ﬁt ten 1 mL  syringes. The ﬂow
rates and the number of auxiliary inputs used were dependent upon
the desired residence time and input HPA concentration (Table 1).
The reactor was  allowed to equilibrate for 2.5 residence times
before sampling began. Samples were collected in pre-weighed
vials containing 270 L 0.1% (v/v) aqueous triﬂuoroacetic acid
(TFA). The quenched samples were weighed, centrifuged and the
supernatant was  diluted 1:1 with 0.1% TFA before being analysed
by HPLC as described in Section 2.1.
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Table  1
Reactor conﬁguration. Conﬁguration of reactor inputs, residence times and ﬂow rates used to perform reactions with different input HPA concentrations and residence times.
HPA input concentration (mM)
200 300 400 500
Residence time (mins) 120 165 264 286
Position Primary 1 TK/HPA TK/HPA TK/HPA TK/HPA
Primary 2 GA GA GA GA
Aux  1 GA GA GA GA
Aux  2 - - GA GA
Aux  3 - - GA GA
Aux  4 GA GA GA GA
Aux  5 - GA GA GA
Aux  6 GA - GA GA
Aux  7 - - - GA
Aux  8 - GA - GA
Aux  9 - - GA -
Aux  10 - - - -
 
 
2
2
B
t
r
f
s
r
T
S
i
cFlow  rate (L min−1) Primary 1 4.49
Primary 2 & Aux 0.24
.5. Fed-batch microplate reactions
Fed-batch reactions were performed in 96-well microplates.
00 L of solution A was made up in each well. 10 L of solution
 was manually added to each well to start the reactions. Fur-
her 10 L doses of solution B were then manually added to the
eaction mixtures at speciﬁc time points, corresponding with the
eeding strategy used in the continuous-ﬂow reactions. Endpoint
amples were taken after the reactions had run for the equivalent
esidence times, diluting 30 L of reaction mixture in 270 L 0.1%
FA. Samples were centrifuged before being analysed by HPLC.
cheme 2. Reactor input layout and in-channel concentrations. Layout of reactor
nputs referred to in Table 1 and concentrations found at inputs and in main reaction
hannel.4.94 8.24 11.90
0.26 0.43 0.63
2.6. 12-h continuous production of ERY
The experiment was run at the conditions of the 500 mM HPA
conversion (Table 1), using the same solutions and reactor setup
as described in Section 2.5. The output tubing from the MIR  was
connected to a RotAXYS auto-sampling system (Cetoni GmbH, Kor-
bussen, Germany), programmed to take 30 L samples every hour
from the start of the reaction. 12 wells of a 96-well plate were each
ﬁlled with 270 L of 0.1% TFA to quench the samples. Samples were
centrifuged before being analysed by HPLC.
3. Results and discussion
3.1. Reactor design
For a typical microreactor consisting of a microchannel with
two (or occasionally more) inputs at one end of the channel, the
substrate concentration is deﬁned at a single point (the input) and
cannot be supplemented further. In such reactor designs, a higher
concentration of product is obtained by increasing the concentra-
tion of substrate at the input. However, in biocatalysis, the effects
of increased substrate concentrations, such as substrate inhibition
and protein denaturation, set limits on the amount of substrate that
can be added at a single point.
In the case of the TK-catalysed synthesis of ERY, we have
observed an increase in reaction rate and yield with increased HPA
and GA input, up to concentrations of 300 mM GA. It has previously
been shown that GA concentrations of 500 mM GA cause a signiﬁ-
cant reduction in the activity half-life of TK, to 200 min as compared
with 400 min  for a concentration of 250 mM [41].
From our own  observations when performing microﬂuidic reac-
tions with GA concentrations of 500 mM,  it becomes clear from
visual inspection that a build-up of solid material is occurring,
causing the reactor channel to clog. This severely impairs the func-
tionality of the reactor, usually halting the ﬂow before it has time
to equilibrate. We therefore decided to explore whether feeding
strategies, analogous to those used in fed-batch processes, could be
used in a continuous-ﬂow microreactor to overcome these limita-
tions. It would thus be worthwhile investigating how to overcome
these problems in order to remove the limitations on the yield of
product that is achievable in biocatalytic microreactors.
To achieve this, we  designed a microﬂuidic reactor with multi-
ple ports, capable of feeding the total amount of substrate across
multiple inputs, and through this enhance the ﬂexibility of microre-
actors for biocatalytic synthesis. Fig. 1 illustrates the design of the
reactor. The design consisted of one main channel with a total
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Fig. 1. Design of the microﬂuidic multi-input reactor (MIR). (A) Top-down layout of channels in the reactor; shaded areas indicate ablated channels, lines indicate cuts
through the substrate, dimensions in mm;  (B) photo of the assembled MIR, showing interconnect bars with (back) and without (front) ﬁttings attached; colored dyes were
used  to visualise the channels (dyes with different colors illustrate the several inputs of the MIR, but are not related to the color scheme of ﬁgures A, C, and D); (C) exploded
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liew  of reactor design also showing interconnect ports (fabricated in PC); (D) section
n  different layers, dimensions in mm.  (For interpretation of the references to color
olume of 1650 L fabricated in poly(methylmethacrylate)
PMMA), with two primary inputs at the front end of the chan-
el where the biocatalyst and substrate were combined to start
he reaction (Fig. 1A). Ten further auxiliary inputs were spaced
venly along the channel, where further substrate could be added.
he inputs were designed for standard ﬁttings, facilitating the easy
econﬁguration of the reactor. PDMS plugs were also designed that
ere compatible with the standard inputs, allowing any unused
nputs to be reliably and reversibly sealed (Fig. 1B). In this way  the
eactor could easily be conﬁgured to test a range of different feeding
trategies.
To enable the conversion of large amounts of substrate, the
eactor was designed to be operated with long residence times,
nd hence required a relatively large total volume. At the same
ime, to allow it to be fabricated on most available laser abla-
ion systems, the outer dimensions of the reactor needed to be
imited to 85 mm × 85 mm.  We  therefore opted for an elegant
esign which divided the channel over two layers, with ‘through-
oles’ ablated into the middle layer to allow ﬂuid to ascend and
escend (Fig. 1C and D). All channels in the reactor had a cross
ection of 1 mm × 0.5 mm,  and the length of individual sections of
he main channel was 60 mm.  Sections of channel on the middle
yellow in Fig. 1) layer were aligned 91◦ from the normal and chan-
els on the base (red) layer were aligned 269◦ from normal. When
onded together, the channels on the different layers aligned to
orm a single channel.
Laser ablation was chosen as the fabrication method for its
apidity. Using the laser, it was possible to fabricate the compar-
tively complex middle layer in less than 6 min  and to complete all
hree layers of the reactor in around 15 min. This ﬁts well with the
rapid prototyping’ paradigm that is a common feature of microﬂu-
dics. A video showing the rapid laser fabrication of the middle
ayer can be found in the Electronic Supplementary Information of the microﬂuidic reactor showing the ‘through-holes’ which connect the channels
t, the reader is referred to the web version of the article.)
1. Given the number of channels and other features involved, fab-
ricating the same design using a micro milling machine, another
commonly used tool for rapid fabrication, would have taken a
few days. As a further advantage, the low cost of PMMA  makes
the reactors very inexpensive to produce, meaning that they can
easily be disposed of and replaced at the end of their useful
life.
The increasing availability of laser ablation systems means
that the reactor could be fabricated by groups without specialist
microﬂuidics knowledge, and the modular design facilitates easy
adaptation to suit the needs of different biocatalytic reactions. The
offset of the auxiliary input ports from the main reactor chan-
nel provides an added beneﬁt, allowing the structure of the main
channel to be changed without modiﬁcation of the port layout.
Decoupling the inputs from the channel in this way means that
the residence volume between individual ports can be adjusted,
for example to allow for shorter residence times between inputs
earlier in the reaction. Combined with the rapidity of the fabri-
cation method, this would allow the production of reactors that
were tailored to the exact substrate feeding schedule required by
the reaction. Additionally, the reactor could be scaled up by sim-
ple modiﬁcations to the design and by use of a larger laser ablation
system. This would then allow bench-top or even pilot scale pro-
duction in continuous-ﬂow, which is of interest to the chemical and
biochemical industries [4].
The ﬂow regime within the main reactor channel was deter-
mined to be laminar, with a Reynolds number of 2.2 × 10−4 at a
ﬂow rate of 10 L min−1 (calculated using the viscosity and density
of water). This was conﬁrmed by confocal imaging of diffusion at a
junction between an auxiliary input and the main channel, where
the ﬂuorescent tracer dye fed though the auxiliary was  shown to
form a lamina over the bulk ﬂuid in the channel (see Electronic
Supplementary Information 2, Fig. S2).
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Fig. 2. End point concentrations of HPA and ERY from TK-catalysed reactions. (A)
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Fig. 3. Throughput, volumetric productivity and conversion data for different reac-
tion  modes.(A) Throughput of ERY from each system; (B) volumetric productivity
(C)  percentage conversion of HPA to ERY. Squares () = fed-batch 96-well plates, tri-ed-batch 96-well plates; (B) microﬂuidic multi-input microﬂuidic reactor. Error
ars  are standard deviation (N = 3). The residence times used for the conversion of
ifferent input HPA concentrations are given in Table 1.
Despite the laminar regime and the absence of mixing struc-
ures, the tracer appeared to be evenly distributed throughout the
hannel within a residence time of 1 min, equivalent to less than
alf the length of a single channel section at the highest ﬂow rates
sed in the synthesis experiments. This is in agreement with the
alculation of the diffusional length of the tracer in the channel,
hich predicts that it will have propagated 0.39 mm across the
hannel depth in 1 min  (where the diffusion coefﬁcient of ﬂuores-
ein in water is 0.64 × 10−9 m2 s−1 [42]).
.2. Performance of the multi-input reactor
The conversion of four different input concentrations of HPA
as carried out in the MIR  and in 96-well microplates, using four
ifferent feeding strategies. In each strategy the conﬁguration or
iming of GA feeding points was altered in order to avoid inhibitory
ffects on the enzyme whilst aiming for complete conversion to
RY. The process of selecting GA feeding points is explained further
n Electronic Supplementary Information 3.
The conﬁgurations used for each HPA input concentration are
hown in Table 1. The ﬂexibility of the reactor was  such that each
f these strategies could be tested with a minimal amount of effort
n setting up, simply by changing the auxiliary connections and ﬂow
ates as required.
Fig. 2 shows the endpoint concentrations of HPA and ERY from
he MIR  and fed-batch microplate well reactions. Compared with
ur own single substrate input microﬂuidic reactor [31], the multi-
oint feeding strategy increased the yield of product from 50 mM
o a maximum of 224 mM with the MIR  (Fig. 2B). Compensatingangles () = microﬂuidic multi-input reactor. Error bars refer to standard deviation
(N  = 3).
for the dilution caused by the nine GA inputs used in the feeding
strategy, the maximum concentration of ERY generated is 313 mM.
Fig. 3 shows the conversion, throughput and volumetric pro-
ductivity data from the MIR  and equivalent fed-batch microplate
well reactions. Comparing the output from the respective systems,
we see a very large improvement in the throughput of ERY from
the MIR, regardless of the input HPA concentration used, with the
highest observed increase being 8-fold at the lowest concentration
(Fig. 3A). By comparison with our single substrate input reactor
we also see an increase in throughput from 3 mg h−1 to 15 mg h−1.
This clearly shows the improvements in throughput and space-time
116 J. Lawrence et al. / Journal of Molecular Cata
Fig. 4. Proﬁle of output concentrations from a 12-h continuous reaction run. Output
concentrations of HPA (diamonds, ) and ERY (squares, ) from reaction run for
12  h using 500 mM input HPA concentration, 9 GA inputs and 286-min residence
time (N = 1). Time refers to the number of hours elapsed after ﬂow was started. No
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tPA/ERY was  recorded for the ﬁrst 3 h as the reaction mixture had not yet reached
he  output. The line indicates an estimate of the cumulative weight of ERY produced
ver the course of the run.
ield that are the foremost advantage of continuous ﬂow reac-
ors over batch or fed-batch reactors, which is in agreement with
imilar comparisons from the literature [34]. A continuous ﬂow
ystem is also of great interest for use in multi-step synthesis pro-
esses, where a cascade of separate reactors can be created to
erform a complex conversion. The MIR  would be well-suited to
his, having standard interconnect ports that would allow connec-
ion to other reactors or intermediate puriﬁcation steps.
The volumetric productivity and conversion achieved in the MIR
as higher than that of the fed-batch microplate at lower input
PA concentrations, reaching a maximum of 9.4 (g h−1) L−1 and
6% respectively (Fig. 3B and C). At higher HPA concentrations the
onversion and productivity of the fed-batch microplate reactions
urpassed that of the MIR. This may  have been caused by decreasing
H as the reaction progressed, due to the evolution of CO2 as a by-
roduct, which was released to the headspace in the microplates
ut remained in solution in the MIR.
A reaction system designed for synthesis should aim to reach
00% conversion in order to minimise the downstream require-
ent for puriﬁcation, or unintended side reactions when used as
art of a multi-step process. Any change in pH could be mitigated
n a manner analogous to that of a pH-stat reactor. This could be
ccomplished by using some of the auxiliary inputs on the MIR
o feed a base solution, thereby counteracting the pH drop and
llowing complete conversion of substrate to product. However,
o investigate this further would require integration of online pH
onitoring into the MIR; a technology that has thus far only been
sed in cellular microreactors [43].
Fig. 4 shows the output concentration proﬁles of HPA and ERY
rom a reaction performed in the MIR  using the feeding strategy
eveloped for a 500 mM HPA input concentration. The reaction was
ampled every hour with an automated sampling arm. The reaction
quilibrated between hour 4 and 5 (as might be expected given that
he residence time was 286 min), with a maximum output con-
entration of around 400 mM ERY. An estimated 90 mg of ERY was
roduced over the course of the experiment. The output concentra-
ion drops continuously between hours 5 and 12, suggesting decay
n TK activity due to exposure to room temperature conditions. This
ay  provide a further explanation of the decrease in conversion
bserved at higher input HPA concentrations (Fig. 3C). The reac-
ions were each sampled at 2.5 residence times, at between 5 andlysis B: Enzymatic 95 (2013) 111– 117
12 h (depending on the input HPA concentration); Fig. 4 suggests
that the TK activity may  have decayed signiﬁcantly by the time
reactions with longer residence times were sampled.
A further modiﬁcation that could be made to overcome this
problem is the addition of a cooling system to maintain the stabil-
ity of the solubilised enzyme. The enzyme could be thermo-stated
to the desired temperature shortly before it is introduced into the
reactor. A mutant of the TK enzyme with greater temperature sta-
bility could also be used. If the initial concentration of ERY observed
in Fig. 4 could be maintained, this would allow production at a rate
of 19 mg  h−1, and thus would have led to a total of 171 mg  over the
12 h.
4. Conclusion
We  have successfully demonstrated the application of ‘fed-
batch’ like substrate feeding strategies to continuous-ﬂow
microreactor technology to address the limitations of single-
point feeding. Our novel ﬂexible microﬂuidic reactor design offers
numerous input conﬁgurations and we tested different feeding
strategies using the TK-catalysed condensation of HPA and GA as
the test reaction. Furthermore, the design is easily fabricated with
laser ablation, with the potential for modiﬁcation to develop cus-
tomised reactions for different biocatalysts and feeding strategies.
The modularity of the design would also allow the incorporation of
the MIR  into a wider network of reactors and separation technolo-
gies, with the potential to develop multi-step synthetic processes
for complex molecular products.
Using our substrate feeding strategies and the ﬂexibility of the
MIR, we  have greatly improved on the yield of product achieved
with our previous microﬂuidic reactor [31]. The output concentra-
tion of ERY has been increased from 50 mM to 224 mM ERY, the
equivalent of 313 mM if the dilution by GA feeding is compensated
for, without exposing the enzyme to destructive concentrations
of substrate. In addition, we  have shown a 5-fold increase in the
throughput of the MIR  over our previous reactor, to a maximum of
15 mg  h−1, with a maximum 8-fold improvement over fed-batch
microplate reactions. This highlights the primary advantage of
continuous-ﬂow reactors in terms of synthetic productivity.
We have shown that the reactor is capable of very high con-
version for short periods of time, but in order to achieve and
maintain full conversion for higher input concentrations further
improvements are necessary, addressing issues of CO2 evolution
and enzyme stability. This would allow the synthesis of ERY at a rate
which would represent a signiﬁcant step towards the high through-
put and output concentrations that are commonly associated with
chemical microreactors.
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